Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,849 | 141,923 | 165,999 | 164,656 | 153,557 |
| Depreciation Amortization | 6,401 | 37,429 | 27,090 | 16,263 | 6,605 |
| Income taxes - deferred | -5,200 | -8,280 | -4,934 | -7,639 | -5,497 |
| Accounts receivable | 9,331 | 68,638 | 24,214 | 1,802 | -32,924 |
| Accounts payable and accrued liabilities | -1,855 | -25,339 | -32,331 | -10,258 | 2,110 |
| Other Working Capital | -4,793 | 2,005 | -21,031 | -9,747 | 14,816 |
| Other Operating Activity | 4,058 | 37,144 | 61,306 | 44,460 | 49,744 |
| Operating Cash Flow | $-7,907 | $253,520 | $220,313 | $199,537 | $188,411 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,518 | -417,982 | -125,554 | -175,056 | -102,373 |
| PPE Investments | -1,836 | -18,363 | -13,813 | -8,600 | -5,346 |
| Net Acquisitions | N/A | -172,679 | -137,755 | -137,755 | N/A |
| Purchase Of Investment | N/A | N/A | -15,000 | -15,000 | N/A |
| Sale Of Investment | N/A | 372,710 | 133,407 | 133,407 | 133,407 |
| Other Investing Activity | 0 | -25,000 | -10,000 | -10,000 | -25,000 |
| Investing Cash Flow | $-4,354 | $-261,314 | $-168,715 | $-213,004 | $688 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -232 | -1,067 | -836 | -598 | -456 |
| Common Stock Issued | N/A | 31 | 19 | 19 | 16 |
| Common Stock Repurchased | -869 | -76,105 | -46,731 | -11,507 | -494 |
| Financing Cash Flow | $-1,101 | $-77,141 | $-47,548 | $-12,086 | $-934 |
| Exchange Rate Effect | 28 | -453 | -174 | -561 | 10 |
| Beginning Cash Position | 79,506 | 164,894 | 164,894 | 164,894 | 164,894 |
| End Cash Position | 66,172 | 79,506 | 168,770 | 138,780 | 353,069 |
| Net Cash Flow | $-13,334 | $-85,388 | $3,876 | $-26,114 | $188,175 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,907 | 253,520 | 220,313 | 199,537 | 188,411 |
| Capital Expenditure | -2,034 | -18,775 | -14,053 | -8,618 | -5,360 |
| Free Cash Flow | -9,941 | 234,745 | 206,260 | 190,919 | 183,051 |